We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stem-Cell Derived Pancreatic Cells Decreased Need for Daily Insulin by 91 Percent
Stem-Cell Derived Pancreatic Cells Decreased Need for Daily Insulin by 91 Percent
Vertex Pharmaceuticals said a patient with a 40-year history of Type 1 diabetes experienced a 91 percent reduction in daily insulin dose after an infusion of its VX-880 stem-cell-derived islet cell replacement therapy.